Greystone Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.83M Buy
13,632
+4,729
+53% +$2.27M 1.91% 25
2026
Q1
$4.38M Sell
8,903
-5,670
-39% -$3.08M 1.24% 37
2025
Q4
$8.44M Sell
14,573
-246
-2% -$139K 1.32% 33
2025
Q3
$7.19M Buy
+14,819
New +$6.9M 1.11% 37
2025
Q2
Sell
-3,453
Closed -$1.72M 106
2025
Q1
$1.72M Sell
3,453
-247
-7% -$134K 0.31% 53
2024
Q4
$1.92M Buy
3,700
+473
+15% +$260K 0.33% 53
2024
Q3
$2M Buy
3,227
+100
+3% +$59.2K 0.36% 50
2024
Q2
$1.73M Buy
3,127
+617
+25% +$353K 0.34% 50
2024
Q1
$1.46M Buy
2,510
+335
+15% +$188K 0.29% 51
2023
Q4
$1.15M Buy
2,175
+703
+48% +$340K 0.27% 56
2023
Q3
$745K Buy
1,472
+39
+3% +$20.8K 0.19% 64
2023
Q2
$748K Buy
+1,433
New +$773K 0.17% 68
2021
Q1
Sell
-4,092
Closed -$2.03M 119
2020
Q4
$2.03M Buy
+4,092
New +$1.92M 0.55% 50

Other funds holding TMO

Greystone Financial Group's TMO Position: Q2 2026 in Review

Greystone Financial Group increased its Thermo Fisher Scientific (TMO) stake by 53% in Q2 2026, buying an estimated $2.27M and bringing the position to 13,632 shares worth $6.83M. The position accounts for 1.91% of the portfolio, ranked #25.

Greystone Financial Group first reported a position in TMO in Q4 2020 and has held it in 13 quarters since. The position peaked at $8.44M in Q4 2025. 1,204 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Greystone Financial Group held 13,632 shares of Thermo Fisher Scientific worth $6.83M as of Q2 2026.
  • Greystone Financial Group bought 4,729 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.27M.
  • Thermo Fisher Scientific made up 1.91% of Greystone Financial Group's portfolio in Q2 2026, its #25 holding.
  • Greystone Financial Group first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 13 quarters since.
  • Greystone Financial Group's Thermo Fisher Scientific position peaked at $8.44M in Q4 2025.
  • 1,204 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Greystone Financial Group's 13F filing for Q2 2026, filed 28 Jul 2026.